# Using BCG Vaccine to Understand Tuberculosis Infection

> **NCT05820594** · NA · UNKNOWN · sponsor: **Liverpool School of Tropical Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** Intradermal BCG (bacillus calmette-guerin) vaccine AJV

## Key facts

- **NCT ID:** NCT05820594
- **Lead sponsor:** Liverpool School of Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-30
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05820594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05820594, "Using BCG Vaccine to Understand Tuberculosis Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05820594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*